SANGAMO THERAPEUTICS, INC. Restructuring Charges
SANGAMO THERAPEUTICS, INC. (SGMOQ) reported Restructuring Charges of -$552.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2026-03-30
- SANGAMO THERAPEUTICS, INC. restructuring charges for the quarter ending 2025-12-31 was $0.00.
- SANGAMO THERAPEUTICS, INC. restructuring charges for the quarter ending 2025-09-30 was $0.00.
- SANGAMO THERAPEUTICS, INC. restructuring charges for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- SANGAMO THERAPEUTICS, INC. restructuring charges for the quarter ending 2025-03-31 was -$552.00K, a 160.59% decline year-over-year.
- SANGAMO THERAPEUTICS, INC. restructuring charges for fiscal 2025 was -$552.00K, a 261.40% decline from fiscal 2024.
- SANGAMO THERAPEUTICS, INC. restructuring charges for fiscal 2024 was $342.00K, a 97.86% decline from fiscal 2023.
- SANGAMO THERAPEUTICS, INC. restructuring charges for fiscal 2023 was $16.02M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month | Restructuring Charges 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $0.00 derived: sum of 3 quarters · filed 2026-03-30 | -$552.00K 10-K · filed 2026-03-30 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | -$552.00K 10-Q · filed 2025-11-06 | -$813.00K derived: sum of 4 quarters · filed 2026-03-30 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$552.00K 10-Q · filed 2025-08-07 | -$813.00K derived: sum of 3 quarters · filed 2026-03-30 | -$2.99M derived: sum of 4 quarters · filed 2026-03-30 | |
| 2025-03-31 | -$552.00K 10-Q · filed 2025-05-12 | -$813.00K derived: sum of 2 quarters · filed 2026-03-30 | -$2.99M derived: sum of 3 quarters · filed 2026-03-30 | -$1.12M derived: sum of 4 quarters · filed 2026-03-30 | |
| 2024-12-31 | -$261.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$2.44M derived: sum of 2 quarters · filed 2026-03-30 | -$569.00K derived: sum of 3 quarters · filed 2026-03-30 | $342.00K 10-K · filed 2026-03-30 | |
| 2024-09-30 | -$2.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$308.00K derived: sum of 2 quarters · filed 2024-11-12 | $603.00K 10-Q · filed 2024-11-12 | $11.28M derived: sum of 4 quarters · filed 2025-03-17 | |
| 2024-06-30 | $1.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $2.78M 10-Q · filed 2024-08-06 | $13.46M derived: sum of 3 quarters · filed 2025-03-17 | $13.46M derived: sum of 4 quarters · filed 2025-03-17 | |
| 2024-03-31 | $911.00K 10-Q · filed 2024-05-09 | $11.59M derived: sum of 2 quarters · filed 2025-03-17 | $11.59M derived: sum of 3 quarters · filed 2025-03-17 | $16.89M derived: sum of 4 quarters · filed 2025-03-17 | |
| 2023-12-31 | $10.68M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $10.68M derived: sum of 2 quarters · filed 2025-03-17 | $15.98M derived: sum of 3 quarters · filed 2025-03-17 | $16.02M 10-K · filed 2025-03-17 | $16.36M 10-K · filed 2024-03-13 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $5.30M derived: sum of 2 quarters · filed 2023-11-01 | $5.34M 10-Q · filed 2023-11-01 | ||
| 2023-06-30 | $5.30M 10-Q · filed 2023-08-08 | $5.34M 10-Q · filed 2023-08-08 |